A detailed history of Susquehanna International Group, LLP transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Susquehanna International Group, LLP holds 147,291 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147,291
Previous 25,501 477.59%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
121,790 Added 477.59%
147,291 $0
Q2 2024

Aug 15, 2024

SELL
N/A
-55,344 Reduced 68.46%
25,501 $0
Q1 2024

May 07, 2024

SELL
N/A
-172,571 Reduced 68.1%
80,845 $0
Q4 2023

Feb 14, 2024

BUY
N/A
77,873 Added 44.36%
253,416 $0
Q3 2023

Nov 14, 2023

BUY
N/A
24,183 Added 15.98%
175,543 $0
Q2 2023

Aug 11, 2023

SELL
N/A
-161,594 Reduced 51.64%
151,360 $0
Q1 2023

May 16, 2023

BUY
N/A
267,008 Added 581.13%
312,954 $0
Q4 2022

Feb 14, 2023

BUY
N/A
45,946 New
45,946 $0
Q2 2022

Aug 15, 2022

BUY
N/A
151,582 New
151,582 $643,000

About ARS PHARMACEUTICALS, INC. COMM


  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.